Baseline anticholinergic burden from medications predicts poorer baseline and long-term health-related quality of life in 16 675 men and women of EPIC-Norfolk prospective population-based cohort study

Funding information Cancer Research UK, Grant/Award Number:C864/A14136; Innes Will Endowed Scholarship, Grant/Award Number: ACAT/DT/2018; Medical Research Council, Grant/Award Numbers: MR/N003284/1, MCUU_12015/1. We would like to thank the participants of EPIC-Norfolk study as well as the participating general practitioners and administrative and research staff who make the study possible. The EPIC-Norfolk study (DOI: https://doi.org/10.22025/2019.10.105.00004) has received funding from the Medical Research Council (MR/N003284/1 and MC-UU_12015/1) and Cancer Research UK (C864/A14136). We are grateful to all the participants who have been part of the project and to the many members of the study teams at the University of Cambridge who have enabled this research. KRY was supported by HotStart Undergraduate Scholarship Programme funded by the Development Trust, University of Aberdeen.Peer reviewedPostprin